mannitol has been researched along with Cerebral Infarction, Middle Cerebral Artery in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 8 (47.06) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 5 (29.41) | 2.80 |
Authors | Studies |
---|---|
Attou, R; De Bels, D; Gallerani, A; Gutierrez, LB; Honore, PM; Kaefer, K; Moorthamers, S; Preseau, T; Redant, S | 1 |
Kang, HY; Kim, JH; Lee, SH; Park, DH | 1 |
Altarsha, E; Barlinn, J; Barlinn, K; Moustafa, H; Pallesen, LP; Passauer, J; Prakapenia, A; Puetz, V; Rahmig, J; Reichmann, H; Schneider, H; Schoene, D; Siepmann, T | 1 |
Du, H; He, Y; Hou, Y; Shao, C; Wan, H; Yang, J; Yin, J; Zeng, M; Zhang, Y; Zhou, H; Zhu, J | 1 |
Choi, C; Kang, SH; Kim, HM; Kim, HT; Kim, NK; Kim, OJ; Oh, SH; Park, J; Shon, J | 1 |
Alkhatib, O; Koch, S; Merenda, A; Mohney, N; O'Phelan, K | 1 |
Acosta, S; Borlongan, CV; Lee, JY; Sanberg, PR; Tajiri, N | 1 |
Muntean, W; Pfurtscheller, K; Plecko, B; Senning, B; Sorantin, E; Zobel, G | 1 |
Chen, CB; Deng, YY; Fang, M; Jiang, WQ; Jiang, X; Wang, QS; Zeng, HK | 1 |
Borlongan, CV; Hadman, M; Sanberg, CD; Sanberg, PR | 1 |
Bahn, MM; Maramattom, BV; Wijdicks, EF | 1 |
Bhardwaj, A; Chang, Y; Lin, J; Toung, TJ | 1 |
Kempski, O | 1 |
Bhardwaj, A; Chang, Y; Chen, CH; Chen, TY; Crain, BJ; Toung, TJ | 1 |
Siesjö, BK; Yoshimoto, T | 1 |
Adams, RE; Derdeyn, CP; Diringer, MN; Manno, EM; Powers, WJ; Videen, TO; Zazulia, AR | 1 |
Bhardwaj, A; Hurn, PD; Toung, TJ; Traystman, RJ | 1 |
2 review(s) available for mannitol and Cerebral Infarction, Middle Cerebral Artery
Article | Year |
---|---|
What is the Role of Hyperosmolar Therapy in Hemispheric Stroke Patients?
Topics: Brain Edema; Decompressive Craniectomy; Diuretics, Osmotic; Fluid Therapy; Hemorrhagic Stroke; Humans; Infarction, Middle Cerebral Artery; Intracranial Hypertension; Ischemic Stroke; Mannitol; Osmolar Concentration; Saline Solution, Hypertonic; Water-Electrolyte Balance | 2020 |
Which patient fares worse after early deterioration due to swelling from hemispheric stroke?
Topics: Aged; Brain Edema; Combined Modality Therapy; Consciousness Disorders; Craniotomy; Decompression, Surgical; Disease Progression; Dominance, Cerebral; Encephalocele; Female; Glasgow Coma Scale; Humans; Infarction, Middle Cerebral Artery; Male; Mannitol; Middle Aged; Retrospective Studies; Treatment Outcome | 2004 |
15 other study(ies) available for mannitol and Cerebral Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Study conclude that AKI appears to be a frequent complication of hyperosmolar therapy with glycerol in patients with malignant MCA infarction: we don't agree about the next study to do!
Topics: Acute Kidney Injury; Glycerol; Humans; Infarction, Middle Cerebral Artery; Mannitol; Osmolar Concentration | 2022 |
Mannitol Augments the Effects of Systemical Stem Cell Transplantation without Increasing Cell Migration in a Stroke Animal Model.
Topics: Animals; Cell Movement; Disease Models, Animal; Doublecortin Protein; Infarction, Middle Cerebral Artery; Mannitol; Rats; Stem Cell Transplantation; Stroke | 2020 |
Acute kidney injury in patients with malignant middle cerebral artery infarction undergoing hyperosmolar therapy with mannitol.
Topics: Acute Kidney Injury; Hospital Mortality; Humans; Infarction, Middle Cerebral Artery; Mannitol; Renal Dialysis; Retrospective Studies; Risk Factors | 2021 |
Danhong injection enhances the therapeutic effect of mannitol on hemispheric ischemic stroke by ameliorating blood-brain barrier disruption.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cytoskeleton; Disease Models, Animal; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelial Cells; Energy Metabolism; Infarction, Middle Cerebral Artery; Injections; Intercellular Junctions; Ischemic Stroke; Mannitol; Matrix Metalloproteinases; Microvessels; Nervous System Diseases; Neuroprotective Agents; Rats, Sprague-Dawley; Survival Rate | 2021 |
The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model.
Topics: Animals; Chronic Disease; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Doublecortin Protein; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Male; Mannitol; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nerve Regeneration; Rats; Rats, Sprague-Dawley; Stroke; Temozolomide; Treatment Outcome | 2018 |
Breaking the Blood-Brain Barrier With Mannitol to Aid Stem Cell Therapeutics in the Chronic Stroke Brain.
Topics: Animals; Blood-Brain Barrier; Brain; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Fetal Blood; Infarction, Middle Cerebral Artery; Male; Mannitol; Rats; Rats, Sprague-Dawley; Stroke | 2016 |
Malignant stroke in a female adolescent (case presentation).
Topics: Adolescent; Diuretics, Osmotic; Fatal Outcome; Female; Genetic Testing; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Mannitol; Methylenetetrahydrofolate Reductase (NADPH2); Mutation | 2009 |
A comparative study on the efficacy of 10% hypertonic saline and equal volume of 20% mannitol in the treatment of experimentally induced cerebral edema in adult rats.
Topics: Animals; Brain Edema; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Mannitol; Osmotic Pressure; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic | 2010 |
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.
Topics: Animals; Blood-Brain Barrier; Brain; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Diuretics, Osmotic; Infarction, Middle Cerebral Artery; Male; Mannitol; Nerve Growth Factors; Neuroprotective Agents; Psychomotor Performance; Rats; Rats, Sprague-Dawley | 2004 |
Increases in lung and brain water following experimental stroke: effect of mannitol and hypertonic saline.
Topics: Animals; Brain Edema; Dominance, Cerebral; Extravascular Lung Water; Infarction, Middle Cerebral Artery; Male; Mannitol; Pulmonary Edema; Rats; Rats, Wistar; Saline Solution, Hypertonic; Water-Electrolyte Balance | 2005 |
Hypertonic saline and stroke.
Topics: Animals; Brain Edema; Critical Care; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Intracranial Pressure; Mannitol; Rats; Saline Solution, Hypertonic; Treatment Outcome; Water-Electrolyte Balance | 2005 |
Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy.
Topics: Animals; Arginine Vasopressin; Brain Edema; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mannitol; Rats; Rats, Wistar; Saline Solution, Hypertonic; Stroke; Stroke Volume | 2006 |
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.
Topics: Animals; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain Injuries; Carbon Dioxide; Carotid Arteries; Cyclosporine; Diuretics, Osmotic; Hydrogen-Ion Concentration; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Ischemic Attack, Transient; Male; Mannitol; Osmosis; Oxygen; Rats; Rats, Wistar; Sodium Chloride; Tacrolimus; Wounds, Stab | 1999 |
Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Atrophy; Brain; Brain Edema; Brain Mapping; Disease Progression; Dominance, Cerebral; Female; Humans; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Tomography, X-Ray Computed | 2001 |
Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline.
Topics: Analysis of Variance; Animals; Brain Edema; Brain Ischemia; Diuretics; Diuretics, Osmotic; Furosemide; Infarction, Middle Cerebral Artery; Male; Mannitol; Rats; Rats, Wistar; Saline Solution, Hypertonic | 2002 |